Pelvic Floor and Sexual Dysfunction in Women With Sjogren's Syndrome

Akdeniz University94 enrolled

Overview

Sjogren's syndrome (SS) is a chronic, systemic, autoimmune disease characterized by lymphocytic infiltration of all exocrine glands, especially tear and salivary glands, and is more common in women.

Sexual functions are affected by symptoms such as pain, fatigue, stiffness, and hormonal imbalance in rheumatological disorders. Vaginal dryness and dyspepsia negatively affect participation in sexual activity. The aim of the study is to examine the pelvic floor problems of women with SS with a self-report, to compare them with healthy individuals, and finally to examine the relationship between pelvic floor problems and sexual dysfunction.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Sexual Dysfunction Pelvic Floor Disorders Pelvic Organ Prolapse Urinary Incontinence Constipation

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * being between the ages of 18-65 * being a woman, * having sex partner, * no smoking, no alcohol Exclusion Criteria: * physical, psychological, cognitive impairment, * having a non-Sjögren additional disease, * malignancy, * pregnancy, * no urogenital disease, * sarcoidosis, * AIDS, * anticholinergic drug use, * had a gynecological or urological operation other than cesarean

Locations (1)

Ayse Ayan

Antalya, Turkey, Turkey (Türkiye)

Outcomes

Primary Outcomes

Pelvic Floor Distress Inventory PFDI-20

Pelvic Floor Distress Inventory has a total of 20 questions and 3 scales (Urinary Distress Inventory, Pelvic Organ Prolapse Distress Inventory, and Colorectal-Anal Distress Inventory). Each short-form scale demonstrates significant correlation with their long-form scales

Time frame: 1 week

Pelvic Floor Impact Questionnaire PFIQ

Pelvic Floor Impact Questionnaire (PFIQ): The questionnaire has 7 questions and each question has 3 separate responses. The response to each item of satisfaction, impact and worry was rated from 3 (quite a bit) to 0 (not at all) for the PFIQ-7. The mean value for all the answered items within the corresponding scale (possible value 0-3) was estimated, then multiplied by (100/3) to obtain the scale score, range 0-100.

Time frame: 1 week

Female Sexual Dysfunction Index FSFI

The FSFI is a brief questionnaire measure of sexual functioning in women. It was developed for the specific purpose of assessing domains of sexual functioning (e.g. sexual arousal, orgasm, satisfaction, pain) in clinical trials.

Time frame: 1 week

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.